Skip to main content
. 2021 Oct 25;78(12):1–8. doi: 10.1001/jamaneurol.2021.3828

Figure 2. Kaplan-Meier Curves for Time to Primary Outcome Event by Left Ventricular Dysfunction and Assigned Treatment.

Figure 2.

The primary outcome of this study was the primary efficacy outcome of the trial: the composite end point of recurrent stroke or systemic embolism.